NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Texas Original

Texas Original

Private
Bastrop, TexasHealthcare & Life Scienceshttps://texasoriginal.com/

Last Round

Series B

Jun 7, 2021

Total Funding Raised

$26.1M

Company Overview

Texas Original is a pharmaceuticals and biotechnology company that produces and distributes licensed medical cannabis in Texas.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Patient Engagement, D2C Brands

Business Model

B2C

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

medical cannabisTexas Compassionate Use ProgramTCUPmedical marijuanacannabis dispensarymedical cannabis deliverycannabis ediblescannabis tincturesvertically integrated cannabistelemedicineweed deliverymedical cannabis patientcannabis cultivationpharmaceutical-grade cannabis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Texas Original Comparables

Compare Texas Original with similar companies based on industry and business-model similarity.

Texas Original comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmaCann
80%
FLUENT Corp.
79%
Parallel
78%

Texas Original Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 7, 2021
Series AJul 20, 2020

Key People

Founding team and executive leadership

Nico Richardson

Chief Executive Officer, Board Member

Executive Team

Texas Original Investors

Notable investors and investment history

Texas Original investors
InvestorRounds
Pickwick Capital PartnersSeries A
AFI Capital PartnersSeries B
Viridian Capital AdvisorsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    Texas Original has expanded one of its facilities in Texas. The article describes this as a significant development but provides no specific details on the location, size, or nature of the expansion.

  • Oct 21, 2025

    Introduced the state's first full-spectrum RSO oral syringe.

Texas Original Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Texas Original Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Texas Original's valuation, stock price, and market status.

Firmographic Details

HeadquartersBastrop, Texas
Employee Range56
Year Founded2017
Last FundingJun 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.